Have any questions? 706-721-6582 or cts@augusta.edu
| Study Name | Principal Investigator |
|---|---|
| Phase I Study to Determine the Safety and Tolerability of Escalating Doses of Panobinostat (LBH589) in Patients with Sickle Cell Disease | Kutlar, Abdullah |
| The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients with Hematologic Disease | Kutlar, Abdullah |
RESEARCH. INNOVATION. DISCOVERY.